Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Argus Health

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204521

« Back to Dashboard

NDA 204521 describes PIMOZIDE, which is a drug marketed by Par Pharm and is included in one NDA. It is available from two suppliers. Additional details are available on the PIMOZIDE profile page.

The generic ingredient in PIMOZIDE is pimozide. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pimozide profile page.
Summary for 204521
Applicant:Par Pharm
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Pharmacology for NDA: 204521
Medical Subject Heading (MeSH) Categories for 204521
Suppliers and Packaging for NDA: 204521
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PIMOZIDE pimozide TABLET;ORAL 204521 ANDA Par Pharmaceutical, Inc. 49884-347 49884-347-01 100 TABLET in 1 BOTTLE (49884-347-01)
PIMOZIDE pimozide TABLET;ORAL 204521 ANDA Par Pharmaceutical, Inc. 49884-348 49884-348-01 100 TABLET in 1 BOTTLE (49884-348-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Sep 28, 2015TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Sep 28, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Queensland Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.